Mr. Goshen David Miteu, University of North Dakota, Nigeria
Goshen David Miteu is a dynamic biomedical researcher deeply committed to addressing global health challenges through translational science. Currently pursuing a PhD in Biomedical Science at the University of North Dakota, his work focuses on HIV-associated neurocognitive disorders and neurodegenerative diseases. A Commonwealth Scholar and recipient of multiple academic honors, Goshen brings a robust background in biotechnology, biochemistry, and infectious disease research. Beyond the lab, he actively contributes to scientific communication, community engagement, and mentorship through numerous roles, including Diversity Equity and Inclusion (DEI) representation and global mentorship initiatives. Goshen has demonstrated leadership in both academic and professional settings and maintains active affiliations with prestigious scientific societies. A passionate advocate for Sustainable Development Goal 3 (Good Health and Well-being), he blends scientific rigor with social impact, leveraging both wet and dry lab skills. Goshen embodies a commitment to innovation, collaboration, and community-driven research in public health and biomedicine.
Publication Profile
google scholar
🎓 Education
Goshen David Miteu is currently a PhD candidate in Biomedical Science at the University of North Dakota, focusing on neurodegenerative diseases and infectious pathologies. He earned an MSc in Biotechnology with Distinction from the University of Nottingham, UK (2023), where he researched recombinant protein production and RNA helicase purification. His undergraduate degree, a BSc in Biochemistry from Caleb University, Lagos (2020), was completed with First Class Honours (CGPA 4.90/5.0), and he emerged as the overall best graduating student. His BSc thesis centered on the levels of granzymes and TGF-β in HIV-1 infected patients. Goshen has also undertaken various certified professional courses in biotechnology, antimicrobial resistance, Python and R programming, and data visualization. His education is enhanced by prestigious scholarships and has spanned interdisciplinary fields, combining molecular biology, biotechnology, and biomedical science, giving him a broad and deep understanding of human health and disease at the cellular and systemic levels.
💼 Experience
Goshen David Miteu has diverse experience in biomedical research, spanning academia, industry, and public health. He currently serves as a Graduate Research Assistant in Chen’s Lab at the University of North Dakota, contributing to therapeutic development for HIV-associated neurocognitive disorders. Previously, at the Center for Infectious Disease Control and Drug Development, Nigeria, he conducted antimicrobial and phytochemical assays on natural compounds like Moringa oleifera. His industrial stint at Dangote Pasta and Flour Ltd (2019–2020) yielded innovations such as a manual pasta crack test, which improved product reliability. Goshen has also held roles in quality assurance and control, ensuring compliance with food safety regulations. He is an active scientific communicator, leading research teams in the ICORMED Collaborative and Pan African Research Group. His work experience reflects his strong capacity for independent research, cross-functional teamwork, and public health impact, integrating both wet and dry lab methodologies to address complex biomedical problems.
🏆 Honors and Awards
Goshen David Miteu has received numerous accolades recognizing his academic excellence and leadership. He is a recipient of the Commonwealth Shared Scholarship (UK, £50,000) and the University of North Dakota Doctoral Scholarship (~$270,000). In 2024, he was awarded the Campbell Scholarship. His early academic excellence was recognized with awards such as Valedictorian, Overall Best Graduating Student, and Best Student in Biochemistry at Caleb University, where he earned multiple departmental prizes including the Okebukola Science Foundation Prize, Prof Nimbe’s Prize, and the Joseph Ayedun’s Prize. During his National Youth Service Corps (NYSC), he received a State Honors Award for public health outreach. Additional distinctions include awards from the Education USA Membership Program, the i-Scholar Initiative, and various alumni honors. His award trajectory showcases a consistent record of excellence in research, academics, and community service, positioning him as a rising leader in global biomedical science and innovation.
🔬 Research Focus
Goshen David Miteu’s primary research focus is the molecular basis of HIV-associated neurocognitive disorders (HAND). Working in Chen’s Lab at the University of North Dakota, he explores how HIV impacts the central nervous system, leading to cognitive decline. His objective is to define the mechanistic pathways involved in HAND, particularly those related to endolysosomal dysfunction, and leverage this knowledge to develop novel therapeutic targets. His broader interests extend to Alzheimer’s, Parkinson’s, and Huntington’s disease, driven by a vision to address major public health challenges through translational neuroscience and molecular interventions. Goshen also has experience in recombinant protein technology, genomic profiling, and bioinformatics, and has contributed to research in antimicrobial resistance, plant-derived bioactives, and RNA helicases. His research philosophy is anchored in innovation, sustainability, and relevance to global health needs, particularly within the context of the United Nations Sustainable Development Goals (SDGs), especially SDG 3 for Good Health and Wellbeing.
📚 Publications
-
🧬 Aptamer Design as Biosensor to Detect Microbes
-
🧪 Aptamer Design for Allergy Detection
-
💉 Conceptualized a Biosimilar Design to Replace Cancer Treatment with Provenge
-
🧫 Genomic Profiling of Bacillus Subspecies via pCR-4-TOPO Vector Cloning of 16s rRNA Gene
-
🧬 Gateway Cloning of TIR1 Gene into Plasmid Vector pENTER11
-
🌱 Transcriptome Data Analysis on Cytokinin Treatment on Roots of Seedlings
-
🔬 Identification and Characterization of Bacillus Microbiota from Rumex obtusifolius Sample
-
🧫 FDA Approves CASGEVY™: First CRISPR/Cas9 Gene Therapy for Sickle Cell Disease – Review
-
🧪 Culture-Free Biphasic Approach for Early Sepsis Detection – Review Article